Article
Results based on 124 cases of breast cancer and 97 controls from Taiwan suggest that the single nucleotide polymorphism (SNP309) in the MDM2 gene promoter is associated with earlier onset and increased risk of breast cancer.
BMC cancer - 13 Jan 2009
Sun Ying-Fang, Leu Jyh-Der, Chen Su-Mei, Lin I-Feng, Lee Yi-Jang
Abstract excerpt
BACKGROUND: It has been suggested that the single nucleotide polymorphism 309 (SNP309, T -> G) in the promoter region of the MDM2 gene is important for tumor development; however, with regards to breast cancer, inconsistent associations have been reported worldwide. It is speculated that these conflicting results may have arisen due to different patient subgroups and ethnicities studied. For the first time, this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.